ライフサイエンスコーパス: cardiac monitoring

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 presence or absence of post-index ambulatory cardiac monitoring.

2 d with adjuvant trastuzumab require adequate cardiac monitoring.

3 versus non-RCC or in trials with or without cardiac monitoring.

4 red patient-level factors in the adequacy of cardiac monitoring.

5 large proportion of patients had suboptimal cardiac monitoring.

6 diac comorbidities was not a determinant for cardiac monitoring.

7 Of the variance in the adequacy of cardiac monitoring, 15.3% was attributable to physician

8 Increasing the low utilization of cardiac monitoring after stroke could identify undiagnos

9 We describe the patterns of cardiac monitoring and evaluate factors associated with

10 tive clinical studies that incorporate close cardiac monitoring and standardized follow-up in patient

11 Chemotherapy, trastuzumab use, cardiac monitoring, and comorbidities were identified by

12 Pharmacotherapy and cardiac monitoring are effective in the management of ca

13 versible, efforts to improve the adequacy of cardiac monitoring are needed, particularly in vulnerabl

14 have required more stringent and consistent cardiac monitoring criteria and excluded patients with a

15 The utility of noninvasive cardiac monitoring for symptom-rhythm correlation may be

16 iable model, factors associated with optimal cardiac monitoring included a more recent year of diagno

17 Serial cardiac monitoring, including endomyocardial biopsies, w

18 coupling between self-related processing and cardiac monitoring observed here implies that, even in t

19 Specific recommendations were made for cardiac monitoring of patients who receive medications a

20 Cardiac monitoring, pulse oximetry and capnography are u

21 Cardiac monitoring should continue in patients receiving

22 The adequacy of cardiac monitoring was determined.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。